Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singer, P. A.
Right arrow Articles by Mendelssohn, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singer, P. A.
Right arrow Articles by Mendelssohn, D. C.

Journal of the American Society of Nephrology, Vol 6, 1410-1417, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives

PA Singer, EC Thiel, CD Naylor, RM Richardson, H Llewellyn-Thomas, M Goldstein, C Saiphoo, PR Uldall, D Kim and DC Mendelssohn
Centre for Bioethics, University of Toronto, Ontario, Canada.

The purpose of this study was to describe the life-sustaining treatment preferences of dialysis patients and to compare the acceptability of two generic and a disease-specific advance directive (AD). Of 532 potentially eligible hemodialysis patients, 95 (17.9%) participated in the study. These patients completed two generic (the Centre for Bioethics Living Will and the Medical Directive) and one disease- specific (the Dialysis Living Will) AD in a randomized cross-over trial. Treatment preferences were measured by using the Centre for Bioethics Living Will. Acceptability of the AD was measured by using a 13-item advance directive acceptability questionnaire (ADAQ) for each AD, and the advance directive choice questionnaire (ADCQ) to elicit participants' preferred AD. Twenty-five percent of the participants wanted to continue dialysis in case of severe stroke, 19% in severe dementia, and 14% in permanent coma. Averaged across treatments, proportions of participants wanting treatment in various health states were: current health (86%), mild stroke (84%), moderate stroke (60%), severe stroke (21%), mild dementia (78%), moderate dementia (51%), severe dementia (14%), terminal illness (41%), and permanent coma (10%). Averaged across health states, proportions of participants wanting various types of treatment were: dialysis (58%), antibiotics (53%), transfusion (53%), surgery (48%), cardiopulmonary resuscitation (48%), respirator (47%), and tube feeding (41%). Mean ADAQ scores were: Dialysis Living Will, 71%; Centre for Bioethics Living Will, 70%; and Medical Directive, 60% (F = 8.27, P < 0.001 (repeat measures analysis of variance); the Dialysis Living Will and Centre for Bioethics Living Will scored significantly higher than the Medical Directive). The proportion of participants who said they would choose to complete each AD was: Dialysis Living Will, 28%; Centre for Bioethics Living Will, 38%; Medical Directive, 31%; and unsure, 3% (chi 2 = 1.465, df = 2, P = 0.48). In conclusion, twenty-five percent or less of hemodialysis patients want to continue dialysis in three specific health states: severe stroke, severe dementia, and permanent coma. Health states and illness severity, far more than treatment descriptions, influence preferences. Dialysis patients should be offered a generic AD, and some generic AD are more acceptable than others. Only a minority of dialysis patients will complete any AD, but the completion of written AD forms is only one element in the process of advance care planning.


This article has been cited by other articles:


Home page
Med Decis MakingHome page
R. A. Pruchno, E. P. Lemay Jr, L. Feild, and N. G. Levinsky
Predictors of patient treatment preferences and spouse substituted judgments: the case of dialysis continuation.
Med Decis Making, March 1, 2006; 26(2): 112 - 121.
[Abstract] [PDF]


Home page
GerontologistHome page
R. A. Pruchno, E. P. Lemay Jr., L. Feild, and N. G. Levinsky
Spouse as Health Care Proxy for Dialysis Patients: Whose Preferences Matter?
Gerontologist, December 1, 2005; 45(6): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. E. Ostermann and S. R. Nelson
Haemodialysis patients' views on their resuscitation status
Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1644 - 1647.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. E. Ostermann and S. R. Nelson
Haemodialysis patients' views on their resuscitation status
Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1644 - 1647.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
N. K. Choudhry, S. Choudhry, and P. A. Singer
CPR for Patients Labeled DNR: The Role of the Limited Aggressive Therapy Order
Ann Intern Med, January 7, 2003; 138(1): 65 - 68.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
W. D. Smucker, R. M. Houts, J. H. Danks, P. H. Ditto, A. Fagerlin, and K. M. Coppola
Modal Preferences Predict Elderly Patients' Life-sustaining Treatment Choices as Well as Patients' Chosen Surrogates Do
Med Decis Making, July 1, 2000; 20(3): 271 - 280.
[Abstract] [PDF]


Home page
JAMAHome page
P. A. Singer, D. K. Martin, and M. Kelner
Quality End-of-Life Care: Patients' Perspectives
JAMA, January 13, 1999; 281(2): 163 - 168.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. A. Singer, D. K. Martin, J. V. Lavery, E. C. Thiel, M. Kelner, and D. C. Mendelssohn
Reconceptualizing Advance Care Planning From the Patient's Perspective
Arch Intern Med, April 27, 1998; 158(8): 879 - 884.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP